Increase of inquiry in the field of propylene glycol raw materials

ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
Triclosana href='https://www.echemi.com/products/pid_Seven3714-triclocarban.html'>Triclocarban.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dow's Thailand Map Ta Phut Propylene Glycol Plant Receives ISCC PLUS Certification
-
ECHEMI High Quality Inquiries (27-31 July)
-
ECHEMI High Quality Inquiries (1-5 July)
-
2024 ECHEMI International Match Meeting of Chemical Raw Materials
-
2024 ECHEMI International Match Meeting of Chemical Raw Materials
-
Price increase! Raw materials soared 10%, price letter to the factory in advance!
-
Kiehl's Dermatologist Solutions Powerful-strength Line-reducing Concentrate
-
Dow and Evonik Initiate Operations of Pilot Plant Converting Hydrogen Peroxide to Propylene Glycol
-
Leakage Accident Turns Pristine Waters of Nago, Japan into Red: Propylene Glycol Safety Concerns Arise
-
BASF to build neopentyl glycol plant at Zhanjiang integration site
Recommend Reading
-
Kemira to Acquire Water Engineering for USD 150 Million
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Process
-
Aramco Acquires Sumitomo’s Stake for $702 Million, Boosting Control of Petro Rabigh to 60% — What Global Ambitions Does This Move Reveal?
-
The Shipping Cold War Sets Sail: The Triple Game Behind China’s Sanctions on Hanwha Ocean
-
German Chemical Industry Output Slumps to Lowest Utilization Rate Since 1991
-
February phosphate market trend shows strong increase in China
-
Crude oil prices fall, retail prices of refined oil products in China continue to decrease
-
Methanol market conditions continue to be weak in China
-
This week, the Chinese epichlorohydrin market showed an upward trend (7.13-7.17)
-
Supply and Demand Sluggish, Toluene Market Makes Minor Adjustments